cjc-1295 ipamorelin human trials gh spikes lean mass gain and Sermorelin: The Power Duo for Growth Hormone Release CJC-1295 and Ipamorelin Peptide Injection
Description
Its N-terminal trans-3-hexenoic acid modification gives it substantially greater enzymatic stability than native GHRH documented as approximately 49-fold more potent than the endogenous peptide in rat pituitary cell studies
Increases SIRT-1 activity as a result of enhanced NAD+ salvage, leading to beneficial epigenetic and metabolic reprogramming, including increased oxidative phosphorylation (OXPHOS) and muscle stem cell activation 1-3
Treasure Island, FL, USA: 2020
[DOI] [PubMed] [Google Scholar] 55.Xie J., Song W., Liang X., Zhang Q., Shi Y., Liu W., Shi X
